Vote for your favorite mineral in #MinCup25! - Paddlewheelite vs. Mannardite
It's a battle of the tiny as bright green #paddlewheelite goes up against jet black #mannardite. Both are small yet mighty minerals, but only one can win!
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2013, November) Reactions Weekly Vol. 1476 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2013 (November)Volume1476
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13307301Long-form Identifiermindat:1:5:13307301:2
GUID0
Full Reference(2013, November) Reactions Weekly Vol. 1476 (1) Springer Science and Business Media LLC
Plain Text(2013, November) Reactions Weekly Vol. 1476 (1) Springer Science and Business Media LLC
In(2013) Reactions Weekly Vol. 1476. Springer Science and Business Media LLC

Contains

(2013) Metoclopramide in pregnancy: new safety data reassuring. Reactions Weekly, 1476 (1) 1 doi:10.1007/s40278-013-6838-8
(2013) Statins provide no net benefit for low-risk patients. Reactions Weekly, 1476 (1) 2 doi:10.1007/s40278-013-6839-7
(2013) GI bleeding with complex antithrombotic therapy in elderly. Reactions Weekly, 1476 (1) 2 doi:10.1007/s40278-013-6840-1
(2013) Varenicline not linked with neuropsychiatric adverse events. Reactions Weekly, 1476 (1) 2 doi:10.1007/s40278-013-6841-0
(2013) Prasugrel prior to PCI: ACCOAST findings challenge current practice. Reactions Weekly, 1476 (1) 3 doi:10.1007/s40278-013-6842-z
(2013) Metabolic effects may be fewer with quetiapine than olanzapine. Reactions Weekly, 1476 (1) 3 doi:10.1007/s40278-013-6843-y
(2013) Risk of med errors, trastuzumab & trastuzumab emtansine confusion. Reactions Weekly, 1476 (1) 4 doi:10.1007/s40278-013-6844-x
(2013) Hypocalcaemia linked to QT prolongation in Sensipar users. Reactions Weekly, 1476 (1) 4 doi:10.1007/s40278-013-6845-9
(2013) Indian govt agrees to tighten clearances for clinical drug testing. Reactions Weekly, 1476 (1) 4 doi:10.1007/s40278-013-6846-8
(2013) EMA restricts use of IV nicardipine. Reactions Weekly, 1476 (1) 4 doi:10.1007/s40278-013-6847-7
(2013) Novo Nordisk recalls incorrectly filled insulin cartridges. Reactions Weekly, 1476 (1) 4 doi:10.1007/s40278-013-6848-6
(2013) Adalimumab. Reactions Weekly, 1476 (1) 5 doi:10.1007/s40278-013-6849-5
(2013) Adalimumab. Reactions Weekly, 1476 (1) 5 doi:10.1007/s40278-013-6850-z
(2013) Adenosine. Reactions Weekly, 1476 (1) 5 doi:10.1007/s40278-013-6851-y
(2013) Adalimumab/infliximab/ustekinumab. Reactions Weekly, 1476 (1) 5 doi:10.1007/s40278-013-6852-x
(2013) Alternative medicine overdose. Reactions Weekly, 1476 (1) 6 doi:10.1007/s40278-013-6853-9
(2013) Albendazole. Reactions Weekly, 1476 (1) 6 doi:10.1007/s40278-013-6854-8
(2013) Alendronic acid. Reactions Weekly, 1476 (1) 6 doi:10.1007/s40278-013-6855-7
(2013) Alteplase. Reactions Weekly, 1476 (1) 6 doi:10.1007/s40278-013-6856-6
(2013) Amphotericin B. Reactions Weekly, 1476 (1) 7 doi:10.1007/s40278-013-6857-5
(2013) Amantadine/rasagiline/sertraline interaction. Reactions Weekly, 1476 (1) 7 doi:10.1007/s40278-013-6858-4
(2013) Anakinra. Reactions Weekly, 1476 (1) 7 doi:10.1007/s40278-013-6859-3
(2013) Amlodipine/labetolol overdose. Reactions Weekly, 1476 (1) 7 doi:10.1007/s40278-013-6860-x
(2013) Aprepitant/cisplatin/ifosfamide. Reactions Weekly, 1476 (1) 8 doi:10.1007/s40278-013-6861-9
(2013) Baclofen withdrawal. Reactions Weekly, 1476 (1) 8 doi:10.1007/s40278-013-6862-8
(2013) BCG vaccine. Reactions Weekly, 1476 (1) 8 doi:10.1007/s40278-013-6863-7
(2013) Aspirin overdose. Reactions Weekly, 1476 (1) 8 doi:10.1007/s40278-013-6864-6
(2013) Bevacizumab. Reactions Weekly, 1476 (1) 9 doi:10.1007/s40278-013-6865-5
(2013) Bleomycin. Reactions Weekly, 1476 (1) 9 doi:10.1007/s40278-013-6866-4
(2013) Bupropion/duloxetine interaction. Reactions Weekly, 1476 (1) 9 doi:10.1007/s40278-013-6867-3
(2013) Buprenorphine/naloxone. Reactions Weekly, 1476 (1) 9 doi:10.1007/s40278-013-6868-2
(2013) Buprenorphine. Reactions Weekly, 1476 (1) 9 doi:10.1007/s40278-013-6869-1
(2013) Calcitriol/calcium. Reactions Weekly, 1476 (1) 10 doi:10.1007/s40278-013-6870-8
(2013) Calcium acetate. Reactions Weekly, 1476 (1) 10 doi:10.1007/s40278-013-6871-7
(2013) Carboplatin. Reactions Weekly, 1476 (1) 10 doi:10.1007/s40278-013-6872-6
(2013) Bupropion/lipid emulsion. Reactions Weekly, 1476 (1) 10 doi:10.1007/s40278-013-6873-5
(2013) Cephalosporin/diclofenac. Reactions Weekly, 1476 (1) 11 doi:10.1007/s40278-013-6874-4
(2013) Carfilzomib. Reactions Weekly, 1476 (1) 11 doi:10.1007/s40278-013-6875-3
(2013) Ciclosporin. Reactions Weekly, 1476 (1) 11 doi:10.1007/s40278-013-6876-2
(2013) Cefepime. Reactions Weekly, 1476 (1) 11 doi:10.1007/s40278-013-6877-1
(2013) Chloroquine diphosphate overdose. Reactions Weekly, 1476 (1) 11 doi:10.1007/s40278-013-6878-0
(2013) Cisplatin/cyclophosphamide. Reactions Weekly, 1476 (1) 12 doi:10.1007/s40278-013-6879-z
(2013) Cimetidine/metformin. Reactions Weekly, 1476 (1) 12 doi:10.1007/s40278-013-6880-6
(2013) Clozapine. Reactions Weekly, 1476 (1) 12 doi:10.1007/s40278-013-6881-5
(2013) Ciclosporin/itraconazole. Reactions Weekly, 1476 (1) 12 doi:10.1007/s40278-013-6882-4
(2013) Clomethiazole. Reactions Weekly, 1476 (1) 12 doi:10.1007/s40278-013-6883-3
(2013) Clozapine. Reactions Weekly, 1476 (1) 13 doi:10.1007/s40278-013-6884-2
(2013) Clozapine. Reactions Weekly, 1476 (1) 13 doi:10.1007/s40278-013-6885-1
(2013) Dabigatran etexilate. Reactions Weekly, 1476 (1) 13 doi:10.1007/s40278-013-6886-0
(2013) Colchicine/omeprazole overdose. Reactions Weekly, 1476 (1) 13 doi:10.1007/s40278-013-6887-z
(2013) Dabrafenib/vemurafenib. Reactions Weekly, 1476 (1) 14 doi:10.1007/s40278-013-6888-y
(2013) Daptomycin. Reactions Weekly, 1476 (1) 14 doi:10.1007/s40278-013-6889-x
(2013) Daptomycin. Reactions Weekly, 1476 (1) 14 doi:10.1007/s40278-013-6890-4
(2013) Digoxin. Reactions Weekly, 1476 (1) 15 doi:10.1007/s40278-013-6891-3
(2013) Darbepoetin-α/epoetin-β/epoetin-θ. Reactions Weekly, 1476 (1) 15 doi:10.1007/s40278-013-6892-2
(2013) Desflurane. Reactions Weekly, 1476 (1) 15 doi:10.1007/s40278-013-6893-1
(2013) Donepezil overdose. Reactions Weekly, 1476 (1) 15 doi:10.1007/s40278-013-6894-0
(2013) Duloxetine. Reactions Weekly, 1476 (1) 16 doi:10.1007/s40278-013-6895-z
(2013) Duloxetine. Reactions Weekly, 1476 (1) 16 doi:10.1007/s40278-013-6896-y
(2013) Duloxetine. Reactions Weekly, 1476 (1) 16 doi:10.1007/s40278-013-6897-x
(2013) Duloxetine overdose. Reactions Weekly, 1476 (1) 16 doi:10.1007/s40278-013-6898-9
(2013) Dopamine overdose. Reactions Weekly, 1476 (1) 16 doi:10.1007/s40278-013-6899-8
(2013) Enoxaparin sodium. Reactions Weekly, 1476 (1) 17 doi:10.1007/s40278-013-6900-6
(2013) Epinephrine. Reactions Weekly, 1476 (1) 17 doi:10.1007/s40278-013-6901-5
(2013) Epinephrine. Reactions Weekly, 1476 (1) 17 doi:10.1007/s40278-013-6902-4
(2013) Epinephrine/fentanyl/thiopental sodium/vecuronium bromide. Reactions Weekly, 1476 (1) 17 doi:10.1007/s40278-013-6903-3
(2013) Fluorouracil/lisinopril interaction. Reactions Weekly, 1476 (1) 18 doi:10.1007/s40278-013-6904-2
(2013) Fingolimod. Reactions Weekly, 1476 (1) 18 doi:10.1007/s40278-013-6905-1
(2013) Flucloxacillin/gentamicin. Reactions Weekly, 1476 (1) 18 doi:10.1007/s40278-013-6906-0
(2013) Etanercept/infliximab. Reactions Weekly, 1476 (1) 18 doi:10.1007/s40278-013-6907-z
(2013) Fluoxetine. Reactions Weekly, 1476 (1) 19 doi:10.1007/s40278-013-6908-y
(2013) Guanfacine. Reactions Weekly, 1476 (1) 19 doi:10.1007/s40278-013-6909-x
(2013) Guaifenesin/dextromethorphan abuse. Reactions Weekly, 1476 (1) 19 doi:10.1007/s40278-013-6910-4
(2013) Fosphenytoin. Reactions Weekly, 1476 (1) 19 doi:10.1007/s40278-013-6911-3
(2013) Interferon. Reactions Weekly, 1476 (1) 20 doi:10.1007/s40278-013-6912-2
(2013) Iodine radioactive. Reactions Weekly, 1476 (1) 20 doi:10.1007/s40278-013-6913-1
(2013) Interferon-β-1b. Reactions Weekly, 1476 (1) 20 doi:10.1007/s40278-013-6914-0
(2013) Haloperidol. Reactions Weekly, 1476 (1) 20 doi:10.1007/s40278-013-6915-z
(2013) Hydroxychloroquine/oxycodone/paracetamol overdose. Reactions Weekly, 1476 (1) 20 doi:10.1007/s40278-013-6916-y
(2013) Ipilimumab. Reactions Weekly, 1476 (1) 21 doi:10.1007/s40278-013-6917-x
(2013) Linezolid. Reactions Weekly, 1476 (1) 21 doi:10.1007/s40278-013-6918-9
(2013) Levodopa. Reactions Weekly, 1476 (1) 21 doi:10.1007/s40278-013-6919-8
(2013) Ketamine abuse. Reactions Weekly, 1476 (1) 21 doi:10.1007/s40278-013-6920-2
(2013) Lornoxicam. Reactions Weekly, 1476 (1) 22 doi:10.1007/s40278-013-6921-1
(2013) Memantine. Reactions Weekly, 1476 (1) 22 doi:10.1007/s40278-013-6922-0
(2013) Lithium. Reactions Weekly, 1476 (1) 22 doi:10.1007/s40278-013-6923-z
(2013) Lithium overdose. Reactions Weekly, 1476 (1) 22 doi:10.1007/s40278-013-6924-y
(2013) Metaxalone overdose. Reactions Weekly, 1476 (1) 22 doi:10.1007/s40278-013-6925-x
(2013) Metformin. Reactions Weekly, 1476 (1) 23 doi:10.1007/s40278-013-6926-9
(2013) Metformin. Reactions Weekly, 1476 (1) 23 doi:10.1007/s40278-013-6927-8
(2013) Metformin overdose. Reactions Weekly, 1476 (1) 23 doi:10.1007/s40278-013-6928-7
(2013) Methadone overdose. Reactions Weekly, 1476 (1) 23 doi:10.1007/s40278-013-6929-6
(2013) Methylprednisolone sodium succinate. Reactions Weekly, 1476 (1) 24 doi:10.1007/s40278-013-6930-0
(2013) Methylprednisolone. Reactions Weekly, 1476 (1) 24 doi:10.1007/s40278-013-6931-z
(2013) Moxifloxacin. Reactions Weekly, 1476 (1) 24 doi:10.1007/s40278-013-6932-y
(2013) Nitric oxide. Reactions Weekly, 1476 (1) 25 doi:10.1007/s40278-013-6933-x
(2013) Nefopam. Reactions Weekly, 1476 (1) 25 doi:10.1007/s40278-013-6934-9
(2013) Multiple drugs. Reactions Weekly, 1476 (1) 25 doi:10.1007/s40278-013-6935-8
(2013) Olanzapine. Reactions Weekly, 1476 (1) 26 doi:10.1007/s40278-013-6936-7
(2013) Olanzapine. Reactions Weekly, 1476 (1) 26 doi:10.1007/s40278-013-6937-6
(2013) Paracetamol. Reactions Weekly, 1476 (1) 26 doi:10.1007/s40278-013-6938-5
(2013) Paracetamol overdose. Reactions Weekly, 1476 (1) 26 doi:10.1007/s40278-013-6939-4
(2013) Pasireotide. Reactions Weekly, 1476 (1) 27 doi:10.1007/s40278-013-6940-y
(2013) Peginterferon/ribavirin. Reactions Weekly, 1476 (1) 27 doi:10.1007/s40278-013-6941-x
(2013) Peginterferon-α-2b/ribavirin. Reactions Weekly, 1476 (1) 27 doi:10.1007/s40278-013-6942-9
(2013) Paracetamol/diphenhydramine overdose. Reactions Weekly, 1476 (1) 27 doi:10.1007/s40278-013-6943-8
(2013) Phenytoin. Reactions Weekly, 1476 (1) 28 doi:10.1007/s40278-013-6944-7
(2013) Phenytoin/valproic acid. Reactions Weekly, 1476 (1) 28 doi:10.1007/s40278-013-6945-6
(2013) Phenazopyridine. Reactions Weekly, 1476 (1) 28 doi:10.1007/s40278-013-6946-5
(2013) Pioglitazone. Reactions Weekly, 1476 (1) 28 doi:10.1007/s40278-013-6947-4
(2013) Prednisolone. Reactions Weekly, 1476 (1) 29 doi:10.1007/s40278-013-6948-3
(2013) Pivampicillin. Reactions Weekly, 1476 (1) 29 doi:10.1007/s40278-013-6949-2
(2013) Potassium permanganate. Reactions Weekly, 1476 (1) 29 doi:10.1007/s40278-013-6950-9
(2013) Pregabalin. Reactions Weekly, 1476 (1) 30 doi:10.1007/s40278-013-6951-8
(2013) Prednisolone/rituximab. Reactions Weekly, 1476 (1) 30 doi:10.1007/s40278-013-6952-7
(2013) Prednisone/rituximab. Reactions Weekly, 1476 (1) 30 doi:10.1007/s40278-013-6953-6
(2013) Pregabalin. Reactions Weekly, 1476 (1) 30 doi:10.1007/s40278-013-6954-5
(2013) Rituximab. Reactions Weekly, 1476 (1) 31 doi:10.1007/s40278-013-6955-4
(2013) Rivaroxaban. Reactions Weekly, 1476 (1) 31 doi:10.1007/s40278-013-6956-3
(2013) Propafenone. Reactions Weekly, 1476 (1) 31 doi:10.1007/s40278-013-6957-2
(2013) Selenium. Reactions Weekly, 1476 (1) 31 doi:10.1007/s40278-013-6958-1
(2013) Quetiapine. Reactions Weekly, 1476 (1) 31 doi:10.1007/s40278-013-6959-0
(2013) Sertraline. Reactions Weekly, 1476 (1) 32 doi:10.1007/s40278-013-6960-7
(2013) Sorafenib/quizartinib. Reactions Weekly, 1476 (1) 32 doi:10.1007/s40278-013-6961-6
(2013) Tacrolimus/voriconazole interaction. Reactions Weekly, 1476 (1) 32 doi:10.1007/s40278-013-6962-5
(2013) Tretinoin. Reactions Weekly, 1476 (1) 33 doi:10.1007/s40278-013-6963-4
(2013) Varenicline. Reactions Weekly, 1476 (1) 33 doi:10.1007/s40278-013-6964-3
(2013) Ticagrelor. Reactions Weekly, 1476 (1) 33 doi:10.1007/s40278-013-6965-2
(2013) Valproic acid. Reactions Weekly, 1476 (1) 33 doi:10.1007/s40278-013-6966-1
(2013) Zolpidem. Reactions Weekly, 1476 (1) 34 doi:10.1007/s40278-013-6967-0
(2013) Vilazodone overdose. Reactions Weekly, 1476 (1) 34 doi:10.1007/s40278-013-6968-z
(2013) Zoledronic acid. Reactions Weekly, 1476 (1) 34 doi:10.1007/s40278-013-6969-y

See Also

These are possibly similar items as determined by title/reference text matching only.

(2013, November) Reactions Weekly Vol. 1477 (1) Springer Science and Business Media LLC
(2013, November) Reactions Weekly Vol. 1478 (1) Springer Science and Business Media LLC
(2013, November) Reactions Weekly Vol. 1479 (1) Springer Science and Business Media LLC
(2013, November) Reactions Weekly Vol. 1480 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1777 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1778 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1779 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1780 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1781 (1) Springer Science and Business Media LLC
(2021, November) Reactions Weekly Vol. 1882 (1) Springer Science and Business Media LLC
(2021, November) Reactions Weekly Vol. 1881 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 16, 2025 09:27:49
Go to top of page